Literature DB >> 7885352

The movement disorder of adult opsoclonus.

J N Caviness1, P A Forsyth, D D Layton, T J McPhee.   

Abstract

We present three cases of the adult opsoclonus-myoclonus syndrome in patients with systemic carcinoma. In addition to opsoclonus and myoclonus, other clinical components of the syndrome can include ataxia, tremor, gait and stance dysfunction, altered mental status, and head and face dyskinesias. The most common etiologies are idiopathic, paraneoplastic, and infectious encephalitis. Radiographic and pathological studies suggest brain-stem dysfunction with associated cerebellar and/or cerebellar pathway dysfunction. In many cases, there is evidence for the involvement of immunologic and/or inflammatory processes in the pathogenesis of this syndrome. The timely recognition of this syndrome is important because of its implications for the underlying etiology and prognosis. The appearance of this syndrome should prompt the search for an occult malignancy.

Entities:  

Mesh:

Year:  1995        PMID: 7885352     DOI: 10.1002/mds.870100106

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Opsoclonus-Myoclonus syndrome.

Authors:  Marta Esteves Guedes; Ana Catarina Almeida; Maria Sara Patricio; João Marques Costa
Journal:  BMJ Case Rep       Date:  2011-10-28

3.  Opsoclonus-myoclonus as a manifestation of Lyme disease.

Authors:  L Peter; J Jung; C Tilikete; P Ryvlin; F Mauguiere
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

Review 4.  Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.

Authors:  Ronnyson Susano Grativvol; Wagner Cid Palmeira Cavalcante; Luiz Henrique Martins Castro; Ricardo Nitrini; Mateus Mistieri Simabukuro
Journal:  Curr Oncol Rep       Date:  2018-11-10       Impact factor: 5.075

5.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

6.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 7.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 8.  Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas.

Authors:  Francesc Graus; Helena Ariño; Josep Dalmau
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

Review 9.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

10.  Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus.

Authors:  Torrey Boland; Jamie Strause; Myra Hu; Dolores Santamaria; Tsao-Wei Liang; Daniel Kremens; Robert Sergott; Michael Moussouttas
Journal:  Neuroophthalmology       Date:  2012-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.